Sector: Health Care.Industry: Biotechnology
Biophytis SA is a France-based biotechnology company focused on the development of therapeutics that slow the degenerative processes associated with aging and improve functional outcomes for patients suffering from age-related diseases. The company's drug candidate, Sarconeos (BIO101), is an orally administered small molecule in development for the treatment of neuromuscular diseases, including sarcopenia and DMD.

Earnings

see more
Q1 2021Est.ActualSurprise
EPS
(EXPECTED)2021-06-25
REV

Related Companies

TickerCompanyChg %Mkt Cap
BPTSBiophytis0%

Biophytis Frequently Asked Questions

Q

How do I buy Biophytis (BPTS) stock?

A

You can purchase shares of Biophytis (NASDAQ: BPTS) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Biophytis's (BPTS) competitors?

Q

What is the target price for Biophytis (BPTS) stock?

A

There is no analysis for Biophytis

Q

Current Stock Price for Biophytis (BPTS)?

A

The stock price for Biophytis (NASDAQ: BPTS) is $10.93 last updated Thu Jun 10 2021 20:00:00 GMT+0000 (Coordinated Universal Time).

Q

Does Biophytis (BPTS) pay a dividend?

A

There are no upcoming dividends for Biophytis.

Q

When is Biophytis (NASDAQ:BPTS) reporting earnings?

A
Biophytis’s Q1 earnings are confirmed for after-market on June 25, 2021.
Q

Is Biophytis (BPTS) going to split?

A

There is no upcoming split for Biophytis.

Q

What sector and industry does Biophytis (BPTS) operate in?

A

Biophytis is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.